Canada Goose Falls, Celsius Rises, Moderna Slides

On this episode of Stock Movers:

- Canada Goose (GOOS) shares fell today on the news that Barclays was cutting the upscale parka retailer's rating to "underweight" from "equal weight", citing challenging macro pressures.

- Vaccine and biotech stocks, including Moderna (MRNA) plunged after a top regulator left the US Food and Drug Administration, casting deep uncertainty about the future of vaccines and cutting-edge gene therapies. Peter Marks, a key figure overseeing the review and approval of vaccines and other medications, resigned on Friday, citing friction with the views of new Health and Human Services Secretary and longtime vaccine critic Robert F. Kennedy Jr.

- Celsius Holdings (CELH) shares rose to hit its highest intraday level since September after Truist Securities upgraded its recommendation to buy from hold, saying the company’s Alani Nu acquisition gives it an “extremely strong position” in the women’s segment of the US energy drink category.

See omnystudio.com/listener for privacy information.